Sign in

CIK 0001840229 · <br>Emerging growth company

MiNK Therapeutics, Inc.

Sign in to watch
Ticker
INKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
212-994-8250
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
  1. DEF 14A Proxy Proxy Statement
  2. DEF 14A Proxy Proxy Statement
  3. DEF 14A Proxy Proxy Statement
  4. SC 13G Stake Amended Statement of Ownership
  5. DEF 14A Proxy Proxy Statement
  6. SC 13D Stake Beneficial Ownership Report
  7. SC 13D/A Stake Beneficial Ownership Report
  8. SC 13D/A Stake Beneficial Ownership Report
  9. DEF 14A Proxy Proxy Statement
  10. DEF 14A Proxy Proxy Statement
  11. SC 13G Stake Amended Statement of Ownership
  12. SC 13D Stake Beneficial Ownership Report

Page 1 of 1 · 12 filings